106 related articles for article (PubMed ID: 1465853)
1. Characterization of protective anti-Fab autoantibodies in kidney graft recipients.
Süsal C; Groth J; Tanzi-Fetta RF; Kirste G; Doerr C; Terness P; May G; Staehler G; Opelz G
Transplant Proc; 1992 Dec; 24(6):2523-6. PubMed ID: 1465853
[No Abstract] [Full Text] [Related]
2. Pretransplant IgA-anti-hinge and IgA-anti-Fab autoantibody activity is associated with good kidney graft survival.
Süsal C; Kröpelin M; Wiesel M; Staehler G; Groth J; May G; Opelz G
Transplant Proc; 1995 Oct; 27(5):2663-5. PubMed ID: 7482869
[No Abstract] [Full Text] [Related]
3. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
[No Abstract] [Full Text] [Related]
4. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity.
Süsal C; Wiesel M; Staehler G; Groth J; May G; Opelz G
Transplant Proc; 1995 Feb; 27(1):1072-4. PubMed ID: 7878810
[No Abstract] [Full Text] [Related]
5. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
[TBL] [Abstract][Full Text] [Related]
6. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
[No Abstract] [Full Text] [Related]
7. Current experience with renal transplantation across the ABO blood group barrier.
Bryan CF; Nelson PW; Aeder MI; Beck ML; Helling TS; Hughes TM; Luger AM; Pierce GE; Shield CF
Transplant Proc; 1992 Dec; 24(6):2527-9. PubMed ID: 1465854
[No Abstract] [Full Text] [Related]
8. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
Martin S; Dyer PA; Scott PD
Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
[No Abstract] [Full Text] [Related]
9. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
Ramounau-Pigot A; Mourad G; Cristol JP; Argiles A; Seignalet J
Transplant Proc; 1992 Dec; 24(6):2496. PubMed ID: 1465843
[No Abstract] [Full Text] [Related]
10. Patterns of "hidden" humoral allosensitization to HLA-A2 revealed by a simple modification of the standard lymphocytotoxic test.
Bohinjec M; Vidan B
Transplant Proc; 1992 Dec; 24(6):2497-501. PubMed ID: 1465844
[No Abstract] [Full Text] [Related]
11. Role of anti-IgG autoantibodies in kidney transplantation.
Süsal C; Guo ZG; Terness P; Opelz G
Immunol Lett; 1990 Nov; 26(2):121-5. PubMed ID: 2269482
[TBL] [Abstract][Full Text] [Related]
12. Influence of pretransplant antibodies on early renal allograft rejection.
Alarif L; Rodriguez R; Blackburn S; Light JA
Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
[No Abstract] [Full Text] [Related]
13. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
14. Recipient sensitization against donor cells in pre- and/or posttransplantation sera is inversely correlated with graft survival.
Sumitran S; Forsberg I; Lindholm A; Lundgren G; Möller E
Transplant Proc; 1987 Feb; 19(1 Pt 2):1566-7. PubMed ID: 3274384
[No Abstract] [Full Text] [Related]
15. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
[No Abstract] [Full Text] [Related]
16. Consequences of anti-OKT3 antibody development: OKT3 reuse and long-term graft survival.
Shield CF
Transplant Proc; 1993 Apr; 25(2 Suppl 1):81-2. PubMed ID: 8465434
[No Abstract] [Full Text] [Related]
17. Influence of anti-IgG antibodies on graft outcome in live related donor renal transplantation.
Tahir MT; Mehra NK
Transpl Immunol; 1995 Sep; 3(3):240-4. PubMed ID: 8581412
[TBL] [Abstract][Full Text] [Related]
18. Effect of anti-Fab antibodies on renal allografts.
Feduska NJ; Chia D; Terasaki PI; Sugich L
Transplant Proc; 1991 Feb; 23(1 Pt 2):1277-8. PubMed ID: 1989211
[No Abstract] [Full Text] [Related]
19. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
Chia D; Horimi T; Terasaki PI; Hermes M
Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
[TBL] [Abstract][Full Text] [Related]
20. Detection and significance of anti-Fab autoantibody.
Persselin JE; Stevens RH
Monogr Allergy; 1989; 26():74-81. PubMed ID: 2671693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
